The Importance of Lipoprotein (a) Testing for Your Heart Health

cardiologists
May 8
3 min read

Heart disease remains one of the leading causes of death worldwide. While many people focus on common risk factors like cholesterol, blood pressure, and lifestyle habits, there is a lesser-known but significant factor that can affect your heart health: lipoprotein (a), often abbreviated as Lp(a). Understanding whether you should have your lipoprotein (a) measured can be a crucial step in managing your cardiovascular risk.

Lipoprotein (a) is a type of lipoprotein in the blood that carries cholesterol, fats, and proteins. Elevated levels of Lp(a) are linked to an increased risk of heart disease, stroke, and other cardiovascular problems. This blog post explores why testing for lipoprotein (a) matters, who should consider it, and what you can do if your levels are high.

What Is Lipoprotein (a) and Why Does It Matter?

Lipoprotein (a) is a particle in the blood made up of cholesterol, fats, and a specific protein called apolipoprotein(a). It resembles low-density lipoprotein (LDL), often called "bad cholesterol," but with an added protein component that makes it unique.

High levels of Lp(a) contribute to the buildup of plaques in arteries, increasing the risk of atherosclerosis, heart attacks, and strokes. Unlike LDL cholesterol, which can be influenced by diet and exercise, Lp(a) levels are mostly determined by genetics and remain relatively stable throughout life.

Because Lp(a) is not routinely measured in standard cholesterol tests, many people with elevated levels may be unaware of their increased risk.

Who Should Consider Lipoprotein (a) Testing?

Not everyone needs to have their lipoprotein (a) measured. However, certain groups can benefit from this test:

Individuals with a family history of early heart disease: If close relatives had heart attacks or strokes before age 55 (men) or 65 (women), testing Lp(a) can help identify inherited risk.
People with unexplained cardiovascular disease: If you have heart disease but normal cholesterol and blood pressure, elevated Lp(a) might be a hidden factor.
Those with high cholesterol that does not respond well to treatment: Elevated Lp(a) can contribute to persistent cholesterol problems.
Patients with a history of stroke or peripheral artery disease: Lp(a) may play a role in these conditions.
Individuals considering aggressive cholesterol-lowering therapy: Knowing Lp(a) levels can guide treatment decisions.

Discussing your personal and family health history with your healthcare provider can help determine if Lp(a) testing is appropriate for you.

How Is Lipoprotein (a) Measured?

Testing lipoprotein (a) involves a simple blood test. Unlike standard cholesterol panels, this test specifically measures the amount of Lp(a) in your blood, usually reported in milligrams per deciliter (mg/dL) or nanomoles per liter (nmol/L).

Because Lp(a) levels are genetically determined, a single test is usually sufficient. However, some labs may recommend retesting if results are borderline or if treatment decisions depend on the measurement.

What Do Your Lipoprotein (a) Levels Mean?

Interpreting Lp(a) levels can be complex, but here are general guidelines:

Low risk: Less than 30 mg/dL (or less than 75 nmol/L)
Moderate risk: 30 to 50 mg/dL (75 to 125 nmol/L)
High risk: Above 50 mg/dL (125 nmol/L)

Higher levels are associated with a greater risk of cardiovascular disease. However, risk depends on other factors like age, smoking, blood pressure, and overall cholesterol.

What Can You Do If Your Lipoprotein (a) Is High?

Currently, no specific medications directly lower Lp(a) levels in most patients. However, managing overall cardiovascular risk is essential:

Control LDL cholesterol: Statins and other cholesterol-lowering drugs can reduce heart disease risk even if they do not lower Lp(a).
Adopt a heart-healthy lifestyle: Regular exercise, a balanced diet rich in fruits and vegetables, avoiding smoking, and maintaining a healthy weight support heart health.
Consider newer therapies: Some emerging treatments, like PCSK9 inhibitors and antisense oligonucleotides, show promise in lowering Lp(a) but are not yet widely available. Specialist help should be sought.